Furthermore, several studies have demonstrated that the overexpression of PRDX1, PRDX2, and PRDX3 has an important role in many cases of drug resistance and that the therapeutic agents targeting these PRDXs are frequently studied for the treatment of cancer [34]. The gene discussed is PRDX3; the disease is cancer.